Carillon Tower Advisers’s Evolent Health EVH Stock Holding History

Carillon Tower Advisers’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$36M	Sell	2,246,832 -69,086	-3%	-$913K	0.22%	141
2020 Q3	$28.7M	Buy	2,315,918 +69,086	+3%	+$812K	0.38%	75
2020 Q2	$16M	Sell	2,246,832 -246,116	-10%	-$1.65M	0.12%	231
2020 Q1	$12M	Sell	2,492,948 -308,117	-11%	-$2.75M	0.12%	248
2019 Q4	$25.3M	Hold	2,801,065	–	–	0.17%	210
2019 Q3	$20.1M	Buy	2,801,065 +1,167,612	+71%	+$8.38M	0.14%	248
2019 Q2	$13M	Hold	1,633,453	–	–	0.09%	303
2019 Q1	$20.5M	Hold	1,633,453	–	–	0.15%	237
2018 Q4	$32.6M	Hold	1,633,453	–	–	0.28%	141
2018 Q3	$46.4M	Hold	1,633,453	–	–	0.33%	111
2018 Q2	$34.4M	Buy	1,633,453 +687,893	+73%	+$13M	0.27%	139
2018 Q1	$13M	Hold	945,560	–	–	0.1%	266
2017 Q4	$11.6M	Buy	+945,560	New	+$13.3M	0.12%	205

Other funds holding EVH

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Carillon Tower Advisers's EVH Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Evolent Health (EVH) stake by 3% in Q4 2020, selling an estimated $913K and leaving 2,246,832 shares worth $36M. The position accounts for 0.22% of the portfolio, ranked #141.

Carillon Tower Advisers first reported a position in EVH in Q4 2017 and has held it in 13 quarters since. The position peaked at $46.4M in Q3 2018. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

Carillon Tower Advisers held 2,246,832 shares of Evolent Health worth $36M as of Q4 2020.
Carillon Tower Advisers sold 69,086 Evolent Health shares in Q4 2020, an estimated $913K.
Evolent Health made up 0.22% of Carillon Tower Advisers's portfolio in Q4 2020, its #141 holding.
Carillon Tower Advisers first reported a position in Evolent Health in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's Evolent Health position peaked at $46.4M in Q3 2018.
161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.